-
Study aim
-
Determining the effectiveness of transdiagnostic cognitive-behavioral therapy protocol on reducing preclinical symptoms of anxiety and depression, improving emotion regulation, resilience and spiritual health in students
-
Design
-
A randomized, randomized controlled clinical trial on 56 patients.
-
Settings and conduct
-
In this research, after receiving the code of ethics from the ethics committee of Shahid Beheshti University of Medical Sciences, sample people are selected based on the Inclusion criteria, and then after the initial interview according to SCID-5-RV and declaring their willingness to participate in the meetings, explanations They are given about research. All participants complete the DASS, CERQ, CD-RISC, SWB, and CFI questionnaires before starting the treatment during the introductory session and then immediately after the course and 2 months later.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: having preclinical anxiety and depression symptoms based on the cut-off point of a score of 18 and above in the DASS-42 subscale and a score of 16 and above in the anxiety subscale of the DASS-42 scale,
Not suffering from severe psychiatric disorders,
Not using drugs and alcohol in the last three months.
Willingness to participate in research.
Exclusion criteria: receiving cognitive-behavioral interventions for at least 8 sessions in the last 1 year.
-
Intervention groups
-
Intervention group: includes all students of Farhangian University of Tehran province who receive integrated transdiagnostic treatment as a group in 14 sessions of 60 minutes on a weekly basis. The control group includes students who do not receive any intervention.
-
Main outcome variables
-
Connor and Davidson Resilience Scale (CD-RISC), Cognitive Emotion Regulation Questionnaire (CERQ), Depression- Anxiety- Stress Scale (DASS), Cognitive flexibility scale (CFI), Spiritual well-being questionnaire (SWB)